Digital health tools are increasingly bridging communication gaps between urologists and patients, particularly for complex conditions requiring nuanced treatment decisions. This technological shift addresses longstanding barriers including limited health literacy, language differences, and compressed consultation times that often compromise informed consent. The European Association of Urology's comprehensive analysis of generative artificial intelligence applications reveals emerging potential for personalized patient education in urological care. Their scoping review examined 18 observational studies spanning 2023-2025, encompassing 310 real-world patients plus extensive simulated scenarios testing large language models and AI chatbots for urological counseling. The research evaluated accuracy of AI-generated medical information, patient comprehension levels, satisfaction scores, and decisional conflict measures across various urological conditions. These AI systems demonstrated capacity to deliver consistent, accessible explanations of complex urological procedures and treatment options, potentially reducing the cognitive burden on both patients and clinicians during shared decision-making processes. However, this represents early-stage validation of a rapidly evolving technology landscape. The timeframe limitation to recent studies reflects the nascent nature of generative AI in clinical applications, while the relatively small patient cohort suggests cautious implementation rather than widespread adoption. Critical gaps remain regarding long-term patient outcomes, integration with existing healthcare workflows, and regulatory oversight of AI-generated medical advice. The urological specialty's embrace of these tools may signal broader acceptance of AI-augmented patient communication, though rigorous validation against traditional counseling methods remains essential before routine clinical deployment.